Tag Biomarker

Lipidomics of Multiple Sclerosis

In multiple sclerosis (MS), a chronic inflammatory and neurodegenerative disease of the central nervous system, the body attacks the protective myelin sheath of neurons in the brain and the spinal cord. The damaged myelin causes communication problems between the central nervous system and the rest of the body. To this day, there is no cure for MS. Neurobiological researchers believe that MS does not only cause the clinical symptoms we look for as of today but also alters a patient’s lipid metabolism.

read more ➔

Multiomics analysis in CVD research

With an ever-increasing pool of accessible information and new tools to mine huge data sets, biology and medicine are moving from intervention to prevention. Omics sciences such as genomics and lipidomics are strong contributors to this paradigm shift. Being major players in cardiovascular disease research, genomics and lipidomics make a great multiomics pair. It matches the capacity to identify genetic predestinations with one or multiple snapshots of the lipid metabolic status to investigate cardiovascular diseases.

read more ➔

When to eat fatty meals: nutrition researchers discover new “biological lipid metabolism clock”

Just in time of Christmas, scientists from the German Institute for Human Nutrition (DIfE) and Lipotype GmbH have published their results of their research on the influence of fatty breakfasts and dinners on lipid metabolism. Their newly discovered “biological lipid metabolism clock” fills a gap in nutritional medicine to activate nutrition for prevention and intervention, and to research how specific foods at specific times of the day can contribute to our health or disease.

read more ➔